Formosa Laboratories

[Not Yet Scheduled]
Formosa Laboratories provides one-stop CDMO services from small-molecule, polymer API, ADC (Antibody Drug Conjugates) manufacturing, formulation development to state-of-art injectable liquid filling and lyophilization for both cytotoxic and non-cytotoxic drug products.
Notably, for over 25 years, Formosa Laboratories has produced its own APIs and UV-filters in its modern facilities in Taiwan. The GMP facilities have been approved by the DOH, FDA, EDQM, PMDA, and German regulatory authorities.

Ticker:
4746
Exchange:
TPE: TAIEX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Taiwan
Year Founded:
1995
Main Therapeutic Focus:
Lead Product in Development:
APIs in various categories, ADC, Injectable products
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided